Related Experiment Video
Updated: Dec 13, 2025

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn
Fehim Can Sevil1, Hülya Sevil2, Mehmet Tort3
1Department of Cardiovascular Surgery, Afyonkarahisar Health Sciences University Hospital, Turkey.
Insights
Iloprost treatment significantly reduces amputation rates in burn patients with vascular injury. This study found a dramatic decrease in amputations among those receiving iloprost, highlighting its effectiveness.
Area of Science:
- Medical Research
- Burn Treatment
- Vascular Surgery
Background:
- Burn injuries frequently lead to vascular complications, increasing the risk of amputation.
- Effective management of burn-related vascular injury is crucial to prevent limb loss.
- Iloprost, a vasodilator, has shown potential in improving microcirculation.
Purpose of the Study:
- To evaluate the efficacy of iloprost treatment in reducing amputation rates among burn patients.
- To compare amputation incidence in burn patients with vascular injury, with and without iloprost.
- To analyze the impact of iloprost on outcomes for patients experiencing burn-related vascular compromise.
Main Methods:
- Retrospective analysis of 366 adult burn patients treated between 2016 and 2019.
- Data collection included demographics, burn etiology, vascular findings, treatments, and amputation rates.
- Comparison of amputation rates between patients treated with iloprost and those not receiving it.
Main Results:
- Vascular injury occurred in 16.3% of burn patients, with higher incidence in electrical and cold burns.
- Of 60 patients with vascular injury, 21 received iloprost treatment.
- Amputation occurred in only one patient (4.8%) treated with iloprost, versus 19 patients (47.5%) not treated with iloprost (P < .001).
Conclusions:
- Iloprost treatment is highly effective in reducing amputation rates in burn patients with vascular injury.
- Early intervention with iloprost may prevent severe outcomes like amputation.
- Iloprost represents a valuable therapeutic option for managing burn-related vascular complications.
Abstract:
The aim of our study was to demonstrate the decrease in amputation rates with iloprost treatment in patients who develop vascular injury due to burns. The data of 366 adult burn patients who were admitted to the emergency department of our hospital between 2016 and 2019 were analyzed. Demographic characteristics, burn factors, vascular examination findings, medical treatments, amputation rates, and levels were recorded. The amputation rates of the patients who were treated with iloprost and who were not treated with iloprost were compared. The mean age of 366 adult patients treated for burns was 37.8 ± 16.4 years, and of these patients, 220 (59.9%) were under 40 years of age. Although heat burns (n = 331.85%) were the most common burn etiology, it was found that the incidence of vascular injury was higher in burns caused by electricity (11.7%) and cold (3.3%) (P < 0.001). Vascular injury was detected in 60 (16.3%) of the patients and 21 (35%) of these patients were treated with iloprost. Amputation was observed in 20 (5.5%) of all burn patients, but only one of the patients treated with iloprost underwent amputation (P < .001). The individual and social impacts of amputations caused by burns are unquestionable. The authors are of the opinion that iloprost treatment is effective in reducing amputations due to burns.
Related Concept Videos
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care

